Rephonic
Artwork for BioSpace

BioSpace

BioSpace
Inflation Reduction Act
FDA
Antibody-Drug Conjugates
Oncology
Cancer Drugs
CAR T Therapies
Glp-1 Drugs
Wegovy
Novo Nordisk
Drug Pricing
Pfizer
Biologics
Small Molecules
M&A Activity
Biopharma Industry
Malignancies
IPO Market
Abbvie
Medicare
Catalent

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

PublishesDailyEpisodes217Founded2 years ago
Number of ListenersCategories
ScienceLife Sciences

Listen to this Podcast

Artwork for BioSpace

Latest Episodes

In this episode of Denatured, you'll listen to Dr. Marc Hedrick, President and CEO of Plus Therapeutics and Dr. Phil Kantoff, CEO & Co-founder of Convergent Therapeutics. They discuss breakthroughs like alpha-emitting isotopes, supply chain solutions... more

Biogen, Eli Lilly and Merck spent more than $20 billion in the past week to swallow biotechs with approved products or promising drug candidates—representing three of this year’s four biggest takeovers. First, Merck picked up Terns Pharmaceuticals an... more

In this episode, you'll be listening to Sergey Jakimov, managing partner at LongeVC and Artem Trotsyuk, operating partner, US, LongeVC. We discuss how developers in the longevity space should stop chasing aging as an abstract target and concentrate o... more

Immunology & inflammation stole the show this week, as Gilead dropped up to $2.1 billion for Ouro Medicines and its T cell engager OM336—an investment it hopes to split with longtime partner Galapagos. Meanwhile, Sanofi also added a T cell engager in... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Ground Truths
Ground TruthsEric Topol

Recent Guests

Phil Kantoff
CEO and co-founder of Convergent Therapeutics
Episode: The Radiotherapeutics Moment: How Isotopes are Changing Cancer Treatment
Marc Hedrick
President and CEO of Plus Therapeutics
Episode: The Radiotherapeutics Moment: How Isotopes are Changing Cancer Treatment
Sergey Jakimov
Managing Partner, LongeVC
LongeVC
Episode: Beyond Buzzwords in Longevity Investing
Artem Trotsyuk
Operating Partner, US, LongeVC
LongeVC
Episode: Beyond Buzzwords in Longevity Investing
Oxana Iliach
Senior Director Regulatory Strategy
Certara
Episode: From Two Trials to One, Sponsors Face a Higher Standard
Vera Pomerantseva
Director of Risk Management Solutions
eClinical Solutions
Episode: From Two Trials to One, Sponsors Face a Higher Standard
Jason Fontenot
Chief Scientific Officer at Stylus Medicine
Stylus Medicine
Episode: Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead
Emile Nuwaysir
Chairman and CEO of Stylus Medicine
Stylus Medicine
Episode: Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead
Ram May-Ron
Managing Partner at FreeMind Group
FreeMind Group
Episode: From Grants to Family Offices: Building a Unified Financing Strategy in Biotech

Hosts

Jennifer Smith-Parker
Director of Insights at BioSpace; Host/Editor with emphasis on financing and policy in biopharma.
Heather McKenzie
Host of BioSpace's The Weekly; Senior Editor focusing on industry trends and regulatory updates.

Reviews

4.7 out of 5 stars from 31 ratings
  • informative and lively

    Love the podcast. The roundtable discussions are engaging, informative, and lively. The information shared helps keep me current in the biopharma industry.

    Apple Podcasts
    5
    AudraStar
    United States6 months ago
  • Great content, the sound quality needs to improve

    The topics discussed are relevant and interesting. The sound quality needs to improve, especially normalizing the volume of the different speakers and using better microphones to avoid saturation.

    Apple Podcasts
    4
    MarcoMtt
    United Statesa year ago
  • Love this podcast

    Love this pod, keep up the good work!

    Apple Podcasts
    5
    Ddxbsbabs
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Engaging and informative with lively roundtable discussions.
Sound quality varies; volume normalization could improve.
Positive feedback on content and guests, strong overall sentiment.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Beyond Buzzwords in Longevity Investing
Q: What does the regulatory and commercialization path look like today for a startup marketed as longevity-focused?
The path relies on a disease-specific target with clear mechanisms and endpoints, FDA alignment, and a comprehension of how payers will require outcome-based evidence; broader aging claims come later, once a solid regulatory and commercial foundation has been established.
Beyond Buzzwords in Longevity Investing
Q: So what does it actually mean to be a pragmatic longevity investor, and how is that different from a classic biotech fund?
Pragmatic longevity investing focuses on disease mechanisms underlying aging-related conditions, measured endpoints, and real-world applicability, with a rigorous data-driven approach to evidence and regulatory alignment, rather than chasing broad, hype-driven claims about aging itself.
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
Q: What does the first participant dose in the Phase 1-2 Pioneer ALS trial mean?
It turned years of work into something real and signifies a profound partnership with ALS patients.
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
Q: What has changed in our understanding of ALS biology over the last decade?
There has been a transformation in understanding ALS biology, focusing on common pathological mechanisms and better-targeted treatments.
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
Q: How has EverythingALS evolved over the years?
Indu Navar started EverythingALS after her husband's ALS diagnosis to drive patient-centered research and collaboration with pharma.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioSpace

What is BioSpace about and what kind of topics does it cover?

The show concentrates on the financial and strategic side of biopharma, frequently unpacking non-dilutive funding, family-office involvement, and biotech financing strategies. Episodes balance market-wide dynamics—FDA decisions, regulatory shifts, and fundraising climates—with deep dives into company-level financing, leadership changes, and major therapeutic areas such as ALS, cardiovascular disease, obesity, oncology, and neuroscience. A notable strength is the blend of investor and operator perspectives, including financial officers, strategy consultants, and C-suite executives from biotech and pharma, which helps listeners understand both capital markets and development timelines. The program is likely to appeal to senior biotech executi... more

Where can I find podcast stats for BioSpace?

Rephonic provides a wide range of podcast stats for BioSpace. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioSpace and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioSpace get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioSpace, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioSpace?

Rephonic provides comprehensive predictive audience data for BioSpace, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioSpace have?

To see how many followers or subscribers BioSpace has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioSpace?

These podcasts share a similar audience with BioSpace:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. The Long Run with Luke Timmerman
5. Ground Truths

How many episodes of BioSpace are there?

BioSpace launched 2 years ago and published 217 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioSpace?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioSpace?

Rephonic pulls ratings and reviews for BioSpace from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioSpace?

Rephonic provides full transcripts for episodes of BioSpace. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioSpace?

Recent guests on BioSpace include:

1. Phil Kantoff
2. Marc Hedrick
3. Sergey Jakimov
4. Artem Trotsyuk
5. Oxana Iliach
6. Vera Pomerantseva
7. Jason Fontenot
8. Emile Nuwaysir

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days